![](/img/cover-not-exists.png)
Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy
Thorsten Simon, Barbara Hero, Andreas Faldum, Rupert Handgretinger, Martin Schrappe, Thomas Klingebiel, Frank BertholdVolume:
11
Language:
english
DOI:
10.1186/1471-2407-11-21
Date:
December, 2011
File:
PDF, 355 KB
english, 2011